{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/49702-242#drug","name":"Juluca","alternateName":"dolutegravir sodium and rilpivirine hydrochloride","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"49702-242"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA210192"},{"@type":"PropertyValue","propertyID":"UNII","value":"1Q1V9V5WYQ|212WAX8KDD"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"806653d1-bf35-4924-b999-ad5d21821cc1"}],"activeIngredient":"DOLUTEGRAVIR SODIUM, RILPIVIRINE HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"ViiV Healthcare Company"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA210192","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=806653d1-bf35-4924-b999-ad5d21821cc1","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-242"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T11:24:07.088Z"}}